Blog Header

By: Elizabeth Tanner

02 Jan, 2014The Top 10 Reasons You Should Be Reading Open Exchange from Assay Depot

At Open Exchange, we discuss the latest trends in drug development, techniques, and the pharmaceutical industry.  Here are the top posts from 2013….

Read More

31 Dec, 2013CNS Therapeutics: Restrategizing Pharmaceutical Development

The need for CNS therapeutics is on the rise.  Neurological diseases are expected to increase steadily in the coming years.  Previously, we addressed…

Read More

27 Dec, 2013CNS Therapeutics: Is the Risk Worth the Reward?

More than $2 trillion dollars a year are spent on treatments for CNS disorders.  One in three people over 80 currently has Alzheimer’s…

Read More

24 Dec, 2013Happy Holidays From Assay Depot!

Elizabeth Tanner

Read More

19 Dec, 2013CNS Therapeutics: The Next Blockbuster or Bust?

The BRAIN Initiative1 sponsored by the NIH has pushed neuroscience and technology to center stage with President Obama supporting advancing neuroscience.  But the…

Read More